0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Anti-tumor Drug Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-27N2168
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
China Anti tumor Drug Market Report Forecast 2021 2027

China Anti-tumor Drug Market Report & Forecast 2021-2027

Code: QYRE-Auto-27N2168
Report
October 2021
106 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
China Anti-tumor Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Anti-tumor Drug Market Segment Percentages, By Type, 2020 (%)
Cytotoxic Drugs
Non-cytotoxic Drugs
China Anti-tumor Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Anti-tumor Drug Market Segment Percentages, By Application, 2020 (%)
Alkylating Agents
Anti-Metabolism Drugs
Platinum Antineoplastic Agents
Anthracycline Antitumor Drugs
Microtubule Stabilizer
Endocrine Therapy Drugs
Immunotherapy Drugs
Gene Therapy Drugs
Targeted Antineoplastic Drugs
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-tumor Drug revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Anti-tumor Drug revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
1 Introduction to Research & Analysis Reports
1.1 Anti-tumor Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Anti-tumor Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Anti-tumor Drug Overall Market Size
2.1 China Anti-tumor Drug Market Size: 2021 VS 2027
2.2 China Anti-tumor Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-tumor Drug Players in China Market
3.2 Top China Anti-tumor Drug Companies Ranked by Revenue
3.3 China Anti-tumor Drug Revenue by Companies
3.4 Top 3 and Top 5 Anti-tumor Drug Companies in China Market, by Revenue in 2020
3.5 Companies Anti-tumor Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-tumor Drug Players in China Market
3.6.1 List of Tier 1 Anti-tumor Drug Companies in China
3.6.2 List of Tier 2 and Tier 3 Anti-tumor Drug Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Anti-tumor Drug Market Size Markets, 2021 & 2027
4.1.2 Cytotoxic Drugs
4.1.3 Non-cytotoxic Drugs
4.2 By Type - China Anti-tumor Drug Revenue & Forecasts
4.2.1 By Type - China Anti-tumor Drug Revenue, 2016-2021
4.2.2 By Type - China Anti-tumor Drug Revenue, 2022-2027
4.2.3 By Type - China Anti-tumor Drug Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Anti-tumor Drug Market Size, 2021 & 2027
5.1.2 Alkylating Agents
5.1.3 Anti-Metabolism Drugs
5.1.4 Platinum Antineoplastic Agents
5.1.5 Anthracycline Antitumor Drugs
5.1.6 Microtubule Stabilizer
5.1.7 Endocrine Therapy Drugs
5.1.8 Immunotherapy Drugs
5.1.9 Gene Therapy Drugs
5.1.10 Targeted Antineoplastic Drugs
5.2 By Application - China Anti-tumor Drug Revenue & Forecasts
5.2.1 By Application - China Anti-tumor Drug Revenue, 2016-2021
5.2.2 By Application - China Anti-tumor Drug Revenue, 2022-2027
5.2.3 By Application - China Anti-tumor Drug Revenue Market Share, 2016-2027
6 Anti-tumor Drug Companies Profiles
6.1 Roche
6.1.1 Roche Company Details
6.1.2 Roche Business Overview
6.1.3 Roche Anti-tumor Drug Introduction
6.1.4 Roche Anti-tumor Drug Revenue in China Market (2016-2021)
6.1.5 Roche Recent Developments
6.2 Novartis
6.2.1 Novartis Company Details
6.2.2 Novartis Business Overview
6.2.3 Novartis Anti-tumor Drug Introduction
6.2.4 Novartis Anti-tumor Drug Revenue in China Market (2016-2021)
6.2.5 Novartis Recent Developments
6.3 Celgene
6.3.1 Celgene Company Details
6.3.2 Celgene Business Overview
6.3.3 Celgene Anti-tumor Drug Introduction
6.3.4 Celgene Anti-tumor Drug Revenue in China Market (2016-2021)
6.3.5 Celgene Recent Developments
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Company Details
6.4.2 Bristol-Myers Squibb Business Overview
6.4.3 Bristol-Myers Squibb Anti-tumor Drug Introduction
6.4.4 Bristol-Myers Squibb Anti-tumor Drug Revenue in China Market (2016-2021)
6.4.5 Bristol-Myers Squibb Recent Developments
6.5 Amgen
6.5.1 Amgen Company Details
6.5.2 Amgen Business Overview
6.5.3 Amgen Anti-tumor Drug Introduction
6.5.4 Amgen Anti-tumor Drug Revenue in China Market (2016-2021)
6.5.5 Amgen Recent Developments
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Details
6.6.2 Johnson & Johnson Business Overview
6.6.3 Johnson & Johnson Anti-tumor Drug Introduction
6.6.4 Johnson & Johnson Anti-tumor Drug Revenue in China Market (2016-2021)
6.6.5 Johnson & Johnson Recent Developments
6.7 Pfizer
6.7.1 Pfizer Company Details
6.7.2 Pfizer Business Overview
6.7.3 Pfizer Anti-tumor Drug Introduction
6.7.4 Pfizer Anti-tumor Drug Revenue in China Market (2016-2021)
6.7.5 Pfizer Recent Developments
6.8 Takeda
6.8.1 Takeda Company Details
6.8.2 Takeda Business Overview
6.8.3 Takeda Anti-tumor Drug Introduction
6.8.4 Takeda Anti-tumor Drug Revenue in China Market (2016-2021)
6.8.5 Takeda Recent Developments
6.9 Eli Lilly
6.9.1 Eli Lilly Company Details
6.9.2 Eli Lilly Business Overview
6.9.3 Eli Lilly Anti-tumor Drug Introduction
6.9.4 Eli Lilly Anti-tumor Drug Revenue in China Market (2016-2021)
6.9.5 Eli Lilly Recent Developments
6.10 AstraZeneca
6.10.1 AstraZeneca Company Details
6.10.2 AstraZeneca Business Overview
6.10.3 AstraZeneca Anti-tumor Drug Introduction
6.10.4 AstraZeneca Anti-tumor Drug Revenue in China Market (2016-2021)
6.10.5 AstraZeneca Recent Developments
6.11 Astellas
6.11.1 Astellas Company Details
6.11.2 Astellas Business Overview
6.11.3 Astellas Anti-tumor Drug Introduction
6.11.4 Astellas Anti-tumor Drug Revenue in China Market (2016-2021)
6.11.5 Astellas Recent Developments
6.12 Merck & Co
6.12.1 Merck & Co Company Details
6.12.2 Merck & Co Business Overview
6.12.3 Merck & Co Anti-tumor Drug Introduction
6.12.4 Merck & Co Anti-tumor Drug Revenue in China Market (2016-2021)
6.12.5 Merck & Co Recent Developments
6.13 Sanofi
6.13.1 Sanofi Company Details
6.13.2 Sanofi Business Overview
6.13.3 Sanofi Anti-tumor Drug Introduction
6.13.4 Sanofi Anti-tumor Drug Revenue in China Market (2016-2021)
6.13.5 Sanofi Recent Developments
6.14 Bayer
6.14.1 Bayer Company Details
6.14.2 Bayer Business Overview
6.14.3 Bayer Anti-tumor Drug Introduction
6.14.4 Bayer Anti-tumor Drug Revenue in China Market (2016-2021)
6.14.5 Bayer Recent Developments
6.15 Biogen Idec
6.15.1 Biogen Idec Company Details
6.15.2 Biogen Idec Business Overview
6.15.3 Biogen Idec Anti-tumor Drug Introduction
6.15.4 Biogen Idec Anti-tumor Drug Revenue in China Market (2016-2021)
6.15.5 Biogen Idec Recent Developments
6.16 Eisai
6.16.1 Eisai Company Details
6.16.2 Eisai Business Overview
6.16.3 Eisai Anti-tumor Drug Introduction
6.16.4 Eisai Anti-tumor Drug Revenue in China Market (2016-2021)
6.16.5 Eisai Recent Developments
6.17 Teva
6.17.1 Teva Company Details
6.17.2 Teva Business Overview
6.17.3 Teva Anti-tumor Drug Introduction
6.17.4 Teva Anti-tumor Drug Revenue in China Market (2016-2021)
6.17.5 Teva Recent Developments
6.18 Otsuka
6.18.1 Otsuka Company Details
6.18.2 Otsuka Business Overview
6.18.3 Otsuka Anti-tumor Drug Introduction
6.18.4 Otsuka Anti-tumor Drug Revenue in China Market (2016-2021)
6.18.5 Otsuka Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
    Table 1. Anti-tumor Drug Market Opportunities & Trends in China Market
    Table 2. Anti-tumor Drug Market Drivers in China Market
    Table 3. Anti-tumor Drug Market Restraints in China Market
    Table 4. Key Players of Anti-tumor Drug in China Market
    Table 5. Top Anti-tumor Drug Players in China Market, Ranking by Revenue (2019)
    Table 6. China Anti-tumor Drug Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. China Anti-tumor Drug Revenue Share by Companies, 2016-2021
    Table 8. Companies Anti-tumor Drug Product Type
    Table 9. List of Tier 1 Anti-tumor Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Anti-tumor Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – China Anti-tumor Drug Revenue, (US$, Mn), 2021 & 2027
    Table 12. By Type - China Anti-tumor Drug Revenue (US$, Mn), 2016-2021
    Table 13. By Type - China Anti-tumor Drug Revenue (US$, Mn), 2022-2027
    Table 14. By Application – China Anti-tumor Drug Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - China Anti-tumor Drug Revenue (US$, Mn), 2016-2021
    Table 16. By Application - China Anti-tumor Drug Revenue (US$, Mn), 2022-2027
    Table 17. Roche Company Details
    Table 18. Roche Business Overview
    Table 19. Roche Anti-tumor Drug Product
    Table 20. Roche Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 21. Roche Recent Developments
    Table 22. Novartis Company Details
    Table 23. Novartis Business Overview
    Table 24. Novartis Anti-tumor Drug Product
    Table 25. Novartis Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 26. Novartis Recent Developments
    Table 27. Celgene Company Details
    Table 28. Celgene Business Overview
    Table 29. Celgene Anti-tumor Drug Product
    Table 30. Celgene Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 31. Celgene Recent Developments
    Table 32. Bristol-Myers Squibb Company Details
    Table 33. Bristol-Myers Squibb Business Overview
    Table 34. Bristol-Myers Squibb Anti-tumor Drug Product
    Table 35. Bristol-Myers Squibb Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 36. Bristol-Myers Squibb Recent Developments
    Table 37. Amgen Company Details
    Table 38. Amgen Business Overview
    Table 39. Amgen Anti-tumor Drug Product
    Table 40. Amgen Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 41. Amgen Recent Developments
    Table 42. Johnson & Johnson Company Details
    Table 43. Johnson & Johnson Business Overview
    Table 44. Johnson & Johnson Anti-tumor Drug Product
    Table 45. Johnson & Johnson Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 46. Johnson & Johnson Recent Developments
    Table 47. Pfizer Company Details
    Table 48. Pfizer Business Overview
    Table 49. Pfizer Anti-tumor Drug Product
    Table 50. Pfizer Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 51. Pfizer Recent Developments
    Table 52. Takeda Company Details
    Table 53. Takeda Business Overview
    Table 54. Takeda Anti-tumor Drug Product
    Table 55. Takeda Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 56. Takeda Recent Developments
    Table 57. Eli Lilly Company Details
    Table 58. Eli Lilly Business Overview
    Table 59. Eli Lilly Anti-tumor Drug Product
    Table 60. Eli Lilly Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 61. Eli Lilly Recent Developments
    Table 62. AstraZeneca Company Details
    Table 63. AstraZeneca Business Overview
    Table 64. AstraZeneca Anti-tumor Drug Product
    Table 65. AstraZeneca Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 66. AstraZeneca Recent Developments
    Table 67. Astellas Company Details
    Table 68. Astellas Business Overview
    Table 69. Astellas Anti-tumor Drug Product
    Table 70. Astellas Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 71. Astellas Recent Developments
    Table 72. Merck & Co Company Details
    Table 73. Merck & Co Business Overview
    Table 74. Merck & Co Anti-tumor Drug Product
    Table 75. Merck & Co Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 76. Merck & Co Recent Developments
    Table 77. Sanofi Company Details
    Table 78. Sanofi Business Overview
    Table 79. Sanofi Anti-tumor Drug Product
    Table 80. Sanofi Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 81. Sanofi Recent Developments
    Table 82. Bayer Company Details
    Table 83. Bayer Business Overview
    Table 84. Bayer Anti-tumor Drug Product
    Table 85. Bayer Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 86. Bayer Recent Developments
    Table 87. Biogen Idec Business Overview
    Table 88. Biogen Idec Company Details
    Table 89. Biogen Idec Anti-tumor Drug Product
    Table 90. Biogen Idec Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 91. Biogen Idec Recent Developments
    Table 92. Eisai Company Details
    Table 93. Eisai Business Overview
    Table 94. Eisai Anti-tumor Drug Product
    Table 95. Eisai Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 96. Eisai Recent Developments
    Table 97. Teva Company Details
    Table 98. Teva Business Overview
    Table 99. Teva Anti-tumor Drug Product
    Table 100. Teva Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 101. Teva Recent Developments
    Table 102. Otsuka Company Details
    Table 103. Otsuka Business Overview
    Table 104. Otsuka Anti-tumor Drug Product
    Table 105. Otsuka Anti-tumor Drug Revenue in China Market (2016-2021) & (US$ Million)
    Table 106. Otsuka Recent Developments
List of Figures
    Figure 1. Anti-tumor Drug Segment by Type
    Figure 2. Anti-tumor Drug Segment by Application
    Figure 3. China Anti-tumor Drug Market Overview: 2020
    Figure 4. China Anti-tumor Drug Market Size: 2021 VS 2027 (US$, Mn)
    Figure 5. China Anti-tumor Drug Revenue, 2016-2027 (US$, Mn)
    Figure 6. The Top 3 and 5 Players Market Share by Anti-tumor Drug Revenue in 2020
    Figure 7. By Type - China Anti-tumor Drug Revenue Market Share, 2016-2027
    Figure 8. By Application - China Anti-tumor Drug Revenue Market Share, 2016-2027
    Figure 9. Roche Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 10. Novartis Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 11. Celgene Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 12. Bristol-Myers Squibb Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 13. Amgen Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 14. Johnson & Johnson Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 15. Pfizer Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 16. Takeda Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 17. Eli Lilly Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 18. AstraZeneca Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 19. Astellas Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 20. Merck & Co Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 21. Sanofi Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 22. Bayer Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 23. Biogen Idec Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 24. Eisai Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 25. Teva Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 26. Otsuka Anti-tumor Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global and China Membrane Bioreactor MBR Systems Market Insights Forecast to 2027
Global and China Membrane Bioreactor (MBR) Systems Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24N7565
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Oligonucleotide API Market Insights Forecast to 2027
Global and China Oligonucleotide API Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34J7553
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and Japan Prokaryotic Recombinant Protein Market Insights Forecast to 2027
Global and Japan Prokaryotic Recombinant Protein Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20U7714
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Lentiviral Vector In Gene Therapy Market Insights Forecast to 2027
Global and China Lentiviral Vector In Gene Therapy Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-30V7563
Tue Nov 30 00:00:00 UTC 2021

Add to Cart